Regulation of mTORC1 signaling by pH

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Balgi, Aruna D ^a   Diering, Graham H ^a   Donohue, Elizabeth ^a   Lam, Karen K Y ^a   Fonseca, Bruno D ^a,c   Zimmerman, Carla ^a   Numata, Masayuki ^a   Roberge, Michel ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Centre for Drug Research and Development   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAF PROTEIN; TUBERIN; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; UNCLASSIFIED DRUG; MTORC1 COMPLEX, HUMAN; MTORC1 COMPLEX, MOUSE; PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACIDIFICATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FIBROBLAST; GENE; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PH MEASUREMENT; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS COMPLEX 1 GENE; TUBEROUS SCLEROSIS COMPLEX 2 GENE; ANIMAL; CELL LINE; GENETICS; METABOLISM; PH; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; HUMANS; HYDROGEN-ION CONCENTRATION; PHOSPHORYLATION; PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 79959647847     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021549     Document Type: Article

References (59)

1. Fitts RH, (1994) Cellular mechanisms of muscle fatigue. Physiol Rev 74: 49-94.
2. Kraut JA, Madias NE, (2010) Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol 6: 274-285.
3. Yao H, Haddad GG, (2004) Calcium and pH homeostasis in neurons during hypoxia and ischemia. Cell Calcium 36: 247-255.
4. Johnson BA, Weil MH, Tang W, Noc M, McKee D, et al. (1995) Mechanisms of myocardial hypercarbic acidosis during cardiac arrest. J Appl Physiol 78: 1579-1584.
5. LaManna JC, Griffith JK, Cordisco BR, Bell HE, Lin CW, et al. (1995) Rapid recovery of rat brain intracellular pH after cardiac arrest and resuscitation. Brain Res 687: 175-181.
6. Zhang X, Lin Y, Gillies RJ, (2010) Tumor pH and its measurement. J Nucl Med 51: 1167-1170.
7. Becelli R, Renzi G, Morello R, Altieri F, (2007) Intracellular and extracellular tumor pH measurement in a series of patients with oral cancer. J Craniofac Surg 18: 1051-1054.
8. van Sluis R, Bhujwalla ZM, Raghunand N, Ballesteros P, Alvarez J, et al. (1999) In vivo imaging of extracellular pH using 1H MRSI. Magn Reson Med 41: 743-750.
9. Vaupel P, Kallinowski F, Okunieff P, (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465.
10. Karuri AR, Dobrowsky E, Tannock IF, (1993) Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment. Br J Cancer 68: 1080-1087.
11. Pouyssegur J, Franchi A, L'Allemain G, Paris S, (1985) Cytoplasmic pH, a key determinant of growth factor-induced DNA synthesis in quiescent fibroblasts. FEBS Lett 190: 115-119.
12. Chambard JC, Pouyssegur J, (1986) Intracellular pH controls growth factor-induced ribosomal protein S6 phosphorylation and protein synthesis in the G0----G1 transition of fibroblasts. Exp Cell Res 164: 282-294.
13. Bravo R, Macdonald-Bravo H, (1986) Effect of pH on the induction of competence and progression to the S-phase in mouse fibroblasts. FEBS Lett 195: 309-312.
14. Musgrove E, Seaman M, Hedley D, (1987) Relationship between cytoplasmic pH and proliferation during exponential growth and cellular quiescence. Exp Cell Res 172: 65-75.
15. Chiche J, Ilc K, Laferriere J, Trottier E, Dayan F, et al. (2009) Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 69: 358-368.
16. Wakabayashi I, Marumo M, Graziani A, Poteser M, Groschner K, (2006) TRPC4 expression determines sensitivity of the platelet-type capacitative Ca2+ entry channel to intracellular alkalosis. Platelets 17: 454-461.
17. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ, (2007) Potential therapeutic applications of autophagy. Nat Rev Drug Discov 6: 304-312.
18. Hall MN, (2008) mTOR-what does it do? Transplant Proc 40: S5-8.
19. Inoki K, Corradetti MN, Guan KL, (2005) Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37: 19-24.
20. Huang J, Manning BD, (2008) The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412: 179-190.
21. Levraut J, Grimaud D, (2003) Treatment of metabolic acidosis. Curr Opin Crit Care 9: 260-265.
22. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
23. Hresko RC, Mueckler M, (2005) mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 280: 40406-40416.
24. Garcia-Martinez JM, Alessi DR, (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416: 375-385.
25. Diering GH, Mills F, Bamji SX, Numata M, (2011) Regulation of dendritic spine growth through activity-dependent recruitment of brain-enriched Na+/H+ exchanger NHE5. Mol Biol Cell PMID: 21551074.
26. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP, (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121: 179-193.
27. Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, et al. (2008) Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118: 3065-3074.
28. Zang M, Gong J, Luo L, Zhou J, Xiang X, et al. (2008) Characterization of Ser338 phosphorylation for Raf-1 activation. J Biol Chem 283: 31429-31437.
29. Wellbrock C, Karasarides M, Marais R, (2004) The RAF proteins take centre stage. Nat Rev Mol Cell Biol 5: 875-885.
30. Kerkhoff E, Rapp UR, (2001) The Ras-Raf relationship: an unfinished puzzle. Adv Enzyme Regul 41: 261-267.
31. Hardie DG, Scott JW, Pan DA, Hudson ER, (2003) Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546: 113-120.
32. Inoki K, Zhu T, Guan KL, (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115: 577-590.
33. Carling D, Sanders MJ, Woods A, (2008) The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond) 32 (Suppl 4): S55-59.
34. Sofer A, Lei K, Johannessen CM, Ellisen LW, (2005) Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 25: 5834-5845.
35. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, et al. (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18: 2893-2904.
36. DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW, (2008) Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 22: 239-251.
37. Korolchuk VI, Saiki S, Lichtenberg M, Siddiqi FH, Roberts EA, et al. (2011) Lysosomal positioning coordinates cellular nutrient responses. Nat Cell Biol 13: 453-460.
38. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, et al. (2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141: 290-303.
39. Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, et al. (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320: 1496-1501.
40. Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223-1233.
41. Gau CL, Kato-Stankiewicz J, Jiang C, Miyamoto S, Guo L, et al. (2005) Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and-insensitive pathways. Mol Cancer Ther 4: 918-926.
42. England BK, Chastain JL, Mitch WE, (1991) Abnormalities in protein synthesis and degradation induced by extracellular pH in BC3H1 myocytes. Am J Physiol 260: C277-282.
43. Zoncu R, Efeyan A, Sabatini DM, (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.
44. Corradetti MN, Guan KL, (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25: 6347-6360.
45. Reiling JH, Sabatini DM, (2006) Stress and mTORture signaling. Oncogene 25: 6373-6383.
46. Avruch J, Hara K, Lin Y, Liu M, Long X, et al. (2006) Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25: 6361-6372.
47. Menon S, Manning BD, (2008) Common corruption of the mTOR signaling network in human tumors. Oncogene 27 (Suppl 2): S43-51.
48. Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, et al. (2007) Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Res 67: 7106-7112.
49. Udell CM, Rajakulendran T, Sicheri F, Therrien M, (2010) Mechanistic principles of RAF kinase signaling. Cell Mol Life Sci 68 (4): 553-565 DOI:10.1007/s00018-010-0520-6.
50. Kraft CA, Garrido JL, Fluharty E, Leiva-Vega L, Romero G, (2008) Role of phosphatidic acid in the coupling of the ERK cascade. J Biol Chem 283: 36636-36645.
51. Andresen BT, Rizzo MA, Shome K, Romero G, (2002) The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett 531: 65-68.
52. Young BP, Shin JJ, Orij R, Chao JT, Li SC, et al. (2010) Phosphatidic acid is a pH biosensor that links membrane biogenesis to metabolism. Science 329: 1085-1088.
53. Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ, (2007) Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 244: 703-713.
54. Fukumura D, Xu L, Chen Y, Gohongi T, Seed B, et al. (2001) Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 61: 6020-6024.
55. Fischer B, Muller B, Fisch P, Kreutz W, (2000) An acidic microenvironment inhibits antitumoral non-major histocompatibility complex-restricted cytotoxicity: implications for cancer immunotherapy. J Immunother 23: 196-207.
56. Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P, et al. (2009) Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 4: e7124.
57. Robert F, Gao HQ, Donia M, Merrick WC, Hamann MT, et al. (2006) Chlorolissoclimides: new inhibitors of eukaryotic protein synthesis. RNA 12: 717-725.
58. Chaillet JR, Boron WF, (1985) Intracellular calibration of a pH-sensitive dye in isolated, perfused salamander proximal tubules. J Gen Physiol 86: 765-794.
59. Baxter KA, Church J, (1996) Characterization of acid extrusion mechanisms in cultured fetal rat hippocampal neurones. J Physiol 493 (Pt 2): 457-470.